CTORCITIUS ONCOLOGY, INC.同业对比
CITIUS ONCOLOGY, INC. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTOR本股 | $84M#8 | — | 2.1x#4 | — | — | -17.1%#12 | — | -61.3%#5 | — | — | — | — |
| GNLX | $108M#1 | — | 6.7x#10 | 13488.8x#7 | 0.0%#5 | -7.6%#10 | -415175.0%#7 | -199.5%#12 | -424.2%#2 | — | -42.0%#3 | — |
| COYA | $107M#2 | — | 2.5x#6 | 13.5x#3 | 123.6%#1 | -42.6%#14 | -283.9%#4 | -49.0%#4 | — | — | -19.6%#2 | — |
| PLYX | $104M#3 | — | 9.5x#11 | — | — | 70.4%#3 | — | -82.1%#7 | — | — | — | — |
| CPIX | $102M#4 | — | 5.8x#8 | 2.3x#1 | 17.6%#3 | 56.2%#4 | -6.3%#2 | -16.3%#3 | — | — | 100.9%#1 | — |
| ANIX | $92M#5 | — | 6.4x#9 | 439.5x#5 | 0.0%#5 | 13.0%#7 | -5571.9%#6 | -75.5%#6 | -87.0%#1 | — | — | — |
| RLYB | $90M#6 | 3.4x#3 | 1.0x#2 | 104.9x#4 | 34.9%#2 | 84.5%#1 | -3853.6%#5 | -9.5%#2 | — | — | — | — |
| MAIA | $85M#7 | — | 4.1x#7 | — | — | 3.7%#8 | — | -108.3%#10 | — | — | — | — |
| EMMA | $84M#9 | — | — | 6.8x#2 | -25.2%#7 | -16.1%#11 | 1.9%#1 | — | — | 4#2 | — | — |
| ACET | $83M#10 | — | 0.7x#1 | — | — | 0.3%#9 | — | -97.2%#9 | — | — | — | — |
| ALDX | $82M#11 | — | 2.2x#5 | — | — | 39.4%#5 | — | -89.3%#8 | — | — | — | — |
| OSTX | $82M#12 | — | — | — | — | -223.7%#16 | — | — | — | — | — | — |
| FBIO | — | 0.9x#1 | — | — | 9.7%#4 | 76.2%#2 | -111.0%#3 | 22.5%#1 | — | — | — | — |
| TELO | $80M#13 | — | 15.8x#12 | — | — | 37.0%#6 | — | -206.9%#13 | — | — | — | — |
| LNAI | $79M#14 | 1.1x#2 | — | 2413.1x#6 | -47.8%#8 | -101.3%#15 | -576678.5%#8 | — | — | 5#1 | — | — |
| PMVP | $79M#15 | — | 1.1x#3 | — | — | -32.0%#13 | — | -108.7%#11 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-16。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议